Inventor · disambiguated record
Nidhi Arora
Also filed as: ARORA NIDHI
20 granted patents·5 pending applications·79 citations·filing 2005–2025
93Inventor score
Files withJANSSEN PHARMACEUTICA NV8MIRATI THERAPEUTICS INC5ROCHE PALO ALTO LLC5ARORA NIDHI2HOFFMANN LA ROCHE2
Top patents by PatentIndex Score
25 records- 0196US11091495B2Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·4 cites·26 claims
- 0292US11220509B2Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Granted Jan 11, 2022·2 cites·27 claims
- 0391US12065446B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 20, 2024·1 cites·4 claims
- 0491US10717745B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 21, 2020·5 cites·26 claims
- 0590US10934310B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 2, 2021·4 cites·7 claims
- 0688US9255110B2Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulatorsHOFFMANN LA ROCHE·Filed 2014·Granted Feb 9, 2016·11 cites·6 claims
- 0787US7435731B2Substituted pyrazolo[3,4-d]pyrimadines and methods of using the sameROCHE PALO ALTO LLC·Filed 2005·Granted Oct 14, 2008·11 cites·16 claims
- 0886US7495015B2Indazole derivatives and methods for using the sameROCHE PALO ALTO LLC·Filed 2005·Granted Feb 24, 2009·10 cites·8 claims
- 0986US2024383914A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 1085US7452880B2Substituted pyrazolo [3,4-d] pyrimidines and methods of using the sameARORA NIDHI·Filed 2005·Granted Nov 18, 2008·15 cites·12 claims
- 1184US11319329B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·7 claims
- 1282US2025282787A1SUBSTITUTED IMIDAZO[1,2-c]PYRIMIDINES AS PRC2 INHIBITORSMIRATI THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1380US12371435B2Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Jul 29, 2025·0 cites·20 claims
- 1479US9907812B2Conjugate-based antifungal and antibacterial prodrugsBAPAT ABHIJIT S·Filed 2012·Granted Mar 6, 2018·14 cites·16 claims
- 1572US10023589B2Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulatorsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 17, 2018·1 cites·19 claims
- 1666US11485738B2Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·0 cites·18 claims
- 1765US10800792B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 13, 2020·0 cites·4 claims
- 1864US10822348B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·10 claims
- 1958US10689396B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 23, 2020·0 cites·23 claims
- 2052US12448363B2Kinase inhibitorsVIDYA THERAPEUTICS INC·Filed 2021·Granted Oct 21, 2025·0 cites·25 claims
- 2151US2010056535A1Inhibitors of HIV-1 reverse transcriptaseROCHE PALO ALTO LLC·Filed 2009·Application pending·0 cites
- 2249US2012015962A1PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORSARORA NIDHI·Filed 2011·Application pending·0 cites
- 2345US7601726B2Substituted pyrazolo[3,4-d]pyrimidines as p38 MAP kinase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Oct 13, 2009·0 cites·17 claims
- 2445US7566708B2Substituted pyrazolo{3,4-D}pyrimidines as p38 map kinase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Jul 28, 2009·0 cites·3 claims
- 2541US2018214472A1Conjugate-based antifungal and antibacterial prodrugsVYOME BIOSCIENCES PVT LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nidhi Arora files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →